{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T00:35:25Z","timestamp":1708734925720},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,23]]},"DOI":"10.7759\/cureus.54743","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T11:16:02Z","timestamp":1708686962000},"source":"Crossref","is-referenced-by-count":0,"title":["Implications of Progestin-Primed Ovarian Stimulation (PPOS) in a Patient With Diminished Ovarian Reserve (DOR) and Its In Vitro Fertilization (IVF) Outcome"],"prefix":"10.7759","author":[{"given":"Sanket","family":"Mahajan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akash","family":"More","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shilpa","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jarul","family":"Shrivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neha","family":"Nawale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Namrata","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Evaluation of the consequences of double ovarian stimulation through shanghai protocol in patients with poor ovarian respond","volume":"5","author":"Zargar M","year":"2022","unstructured":"Zargar M, Pourjafar Z, Salemi S, Barati M. Evaluation of the consequences of double ovarian stimulation through shanghai protocol in patients with poor ovarian respond. Res Sq. 2022, 5:1-14.","journal-title":"Res Sq"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.4788","article-title":"Diagnosis and management of infertility: a review","volume":"326","author":"Carson SA","year":"2021","unstructured":"Carson SA, Kallen AN. Diagnosis and management of infertility: a review. JAMA. 2021, 326:65-76. 10.1001\/jama.2021.4788","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.18632\/aging.202772","article-title":"Higher chromosomal aberration frequency in products of conception from women older than 32 years old with diminished ovarian reserve undergoing IVF\/ICSI","volume":"13","author":"Zhang W","year":"2021","unstructured":"Zhang W, Zhang L, Liu Y, et al.. Higher chromosomal aberration frequency in products of conception from women older than 32 years old with diminished ovarian reserve undergoing IVF\/ICSI. Aging (Albany NY). 2021, 13:10128-40. 10.18632\/aging.202772","journal-title":"Aging (Albany NY)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2015.03.022","article-title":"Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization","volume":"104","author":"Kuang Y","year":"2015","unstructured":"Kuang Y, Chen Q, Fu Y, et al.. Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization. Fertil Steril. 2015, 104:62-70.e3. 10.1016\/j.fertnstert.2015.03.022","journal-title":"Fertil Steril"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/JCMA.0000000000000177","article-title":"Progestin-primed ovarian stimulation improves the outcomes of IVF\/ICSI cycles in infertile women with diminished ovarian reserve","volume":"82","author":"Yu CM","year":"2019","unstructured":"Yu CM, Dai XL, Wang YF, Gao TT, Cao F, Xia XY, Chen L. Progestin-primed ovarian stimulation improves the outcomes of IVF\/ICSI cycles in infertile women with diminished ovarian reserve. J Chin Med Assoc. 2019, 82:845-8. 10.1097\/JCMA.0000000000000177","journal-title":"J Chin Med Assoc"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.801026","article-title":"Progestin-primed ovarian stimulation versus mild stimulation protocol in advanced age women with diminished ovarian reserve undergoing their first in vitro fertilization cycle: a retrospective cohort study","volume":"12","author":"Tu X","year":"2021","unstructured":"Tu X, You B, Jing M, Lin C, Zhang R. Progestin-primed ovarian stimulation versus mild stimulation protocol in advanced age women with diminished ovarian reserve undergoing their first in vitro fertilization cycle: a retrospective cohort study. Front Endocrinol (Lausanne). 2021, 12:801026. 10.3389\/fendo.2021.801026","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S226414","article-title":"Comparison between PPOS and GnRHa-long protocol in clinical outcome with the first IVF\/ICSI cycle: a randomized clinical trial","volume":"12","author":"Xi Q","year":"2020","unstructured":"Xi Q, Tao Y, Qiu M, Wang Y, Kuang Y. Comparison between PPOS and GnRHa-long protocol in clinical outcome with the first IVF\/ICSI cycle: a randomized clinical trial. Clin Epidemiol. 2020, 12:261-72. 10.2147\/CLEP.S226414","journal-title":"Clin Epidemiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/life11121368","article-title":"The sixth edition of the WHO manual for human semen analysis: a critical review and SWOT analysis","volume":"11","author":"Boitrelle F","year":"2021","unstructured":"Boitrelle F, Shah R, Saleh R, et al.. The sixth edition of the WHO manual for human semen analysis: a critical review and SWOT analysis. Life (Basel). 2021, 11:10.3390\/life11121368","journal-title":"Life (Basel)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-018-0430-z","article-title":"Discordant anti-m\u00fcllerian hormone (AMH) and follicle stimulating hormone (FSH) among women undergoing in vitro fertilization (IVF): which one is the better predictor for live birth?","volume":"11","author":"Wang S","year":"2018","unstructured":"Wang S, Zhang Y, Mensah V, Huber WJ 3rd, Huang YT, Alvero R. Discordant anti-m\u00fcllerian hormone (AMH) and follicle stimulating hormone (FSH) among women undergoing in vitro fertilization (IVF): which one is the better predictor for live birth?. J Ovarian Res. 2018, 11:60. 10.1186\/s13048-018-0430-z","journal-title":"J Ovarian Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1273170","article-title":"The value of luteinizing hormone basal values and sex hormone-binding globulin for early diagnosis of rapidly progressive central precocious puberty","volume":"14","author":"Zhang M","year":"2023","unstructured":"Zhang M, Sun J, Wang Y, et al.. The value of luteinizing hormone basal values and sex hormone-binding globulin for early diagnosis of rapidly progressive central precocious puberty. Front Endocrinol (Lausanne). 2023, 14:1273170. 10.3389\/fendo.2023.1273170","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s12978-023-01671-3","article-title":"Analysis of cumulative live birth rate outcomes of three ovarian stimulation protocols in patients after laparoscopic cystectomy of ovarial endometrioma: a retrospective cohort study","volume":"20","author":"Li J","year":"2023","unstructured":"Li J, Li Y, Li M, et al.. Analysis of cumulative live birth rate outcomes of three ovarian stimulation protocols in patients after laparoscopic cystectomy of ovarial endometrioma: a retrospective cohort study. Reprod Health. 2023, 20:126. 10.1186\/s12978-023-01671-3","journal-title":"Reprod Health"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.702558","article-title":"Progestin-primed ovarian stimulation protocol for patients in assisted reproductive technology: a meta-analysis of randomized controlled trials","volume":"12","author":"Guan S","year":"2021","unstructured":"Guan S, Feng Y, Huang Y, Huang J. Progestin-primed ovarian stimulation protocol for patients in assisted reproductive technology: a meta-analysis of randomized controlled trials. Front Endocrinol (Lausanne). 2021, 12:702558. 10.3389\/fendo.2021.702558","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2020.01.027","article-title":"Progestins versus GnRH analogues for pituitary suppression during ovarian stimulation for assisted reproductive technology: a systematic review and meta-analysis","volume":"40","author":"Alexandru P","year":"2020","unstructured":"Alexandru P, Cekic SG, Yildiz S, Turkgeldi E, Ata B. Progestins versus GnRH analogues for pituitary suppression during ovarian stimulation for assisted reproductive technology: a systematic review and meta-analysis. Reprod Biomed Online. 2020, 40:894-903. 10.1016\/j.rbmo.2020.01.027","journal-title":"Reprod Biomed Online"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0280238","article-title":"Progestin-primed ovarian stimulation for fertility preservation in women with cancer: a comparative study","volume":"18","author":"Filippi F","year":"2023","unstructured":"Filippi F, Reschini M, Polledri E, et al.. Progestin-primed ovarian stimulation for fertility preservation in women with cancer: a comparative study. PLoS One. 2023, 18:e0280238. 10.1371\/journal.pone.0280238","journal-title":"PLoS One"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/231292-implications-of-progestin-primed-ovarian-stimulation-ppos-in-a-patient-with-diminished-ovarian-reserve-dor-and-its-in-vitro-fertilization-ivf-outcome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T11:16:04Z","timestamp":1708686964000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/231292-implications-of-progestin-primed-ovarian-stimulation-ppos-in-a-patient-with-diminished-ovarian-reserve-dor-and-its-in-vitro-fertilization-ivf-outcome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,23]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.54743","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,23]]}}}